logo-loader

Roquefort Therapeutics says new mRNA platform "fits very well"

Published: 07:26 08 Mar 2023 EST

Roquefort Therapeutics PLC (LSE:ROQ, OTCQB:ROQAF) chief executive Ajan Reginald speaks to Proactive's Thomas Warner after announcing the biotech company has developed a new platform of potential anti-cancer messenger RNA (mRNA) therapeutics.

Reginald reveals the reasons for the move, saying that "developing cutting edge medicines using innovative new approaches" is "what Roquefort is all about."

Roquefort Therapeutics seeks to lock in future value with anti-cancer...

Roquefort Therapeutics PLC (LSE:ROQ, OTCQB:ROQAF) chief executive Ajan Reginald speaks to Thomas Warner from Proactive after announcing the successful filing of a global patent for its anti-cancer therapeutics. Once approved, the international phase PCT (patent treaty cooperation) patent would...

on 08/15/2023